Zydus gets USFDA#39;s nod for antipsychotic drug, stock flat on January 18, 2024 at 4:27 am

Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis.

Leave a comment

Your email address will not be published. Required fields are marked *